Darovasertib is an Orally Active PKC Inhibitor for Uveal Melanoma Research
Uveal melanoma (UM) is a common type of primary intraocular cancers. Besides, primary uveal melanoma has high risk of progressing to metastatic uveal melanoma with a poor prognosis. Therefore, it’s…